FDA Adverse Event Malfunction Summary report: N

ARCHITECT CA 19-9XR

MDR report key: 3000257 · Received March 12, 2013

Report

Report Number
1415939-2013-00142
Event Type
Malfunction
Date Received
March 12, 2013
Date of Event
January 25, 2013
Report Date
March 5, 2013
Manufacturer
ABBOTT LABORATORIES
Product Code
NIG
PMA / PMN Number
K052000
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVALUATION WAS PERFORMED IN ORDER TO INVESTIGATE THIS ISSUE. ACCURACY TESTING WAS COMPLETED USING PANELS AND THE LIKELY CAUSE LOT SHOWED THAT IT CAN ACCURATELY DETECT KNOWN CONCENTRATIONS OF THE ASSAY. THE TREND REVIEW IDENTIFIED NORMAL COMPLAINT ACTIVITY FOR THE ISSUE UNDER INVESTIGATION. BASED ON THE EVALUATION RESULTS, NO PRODUCT DEFICIENCY OR MALFUNCTION WERE IDENTIFIED TO BE RELATED TO THIS ISSUE AS THE INCIDENT WAS LIMITED TO A SINGLE PATIENT SAMPLE. TESTING OF A NEW SAMPLE WITH THE SAME LOT GENERATED A LOWER RESULT.

Additional Manufacturer Narrative · 1

THIS REPORT IS BEING FILED AGAINST AN EX-US PRODUCT (2K91-25) THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US (2K91-27). (B)(4). PRODUCT EVALUATION IS IN PROCESS AND THE RESULTS WILL BE SUBMITTED IN A FOLLOW-UP REPORT.

Description of Event or Problem · 1

THE CUSTOMER STATED THAT ONE PATIENT SAMPLE GENERATED A HIGHER THAN EXPECTED RESULT FOR THE ARCHITECT CA19-9XR ASSAY. THE PATIENT WAS MONITORED WITH RESULTS AS FOLLOWS:A RESULT OF 9.2 U/ML WAS OBTAINED BACK IN (B)(6) 2012. RESULTS OF 45.5 AND 43.9 U/ML WERE GENERATED IN (B)(6) 2013 AND A RESULT OF 8.1 U/ML WAS GENERATED IN (B)(6) 2013. THE CUSTOMER SUSPECTED THE RESULTS GENERATED IN (B)(6). NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
103223 ARCHITECT CA 19-9XR NIG ABBOTT LABORATORIES 18069M500

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT ANALYZER 08C89-01 SN (B)(4)